Regulation of apoptosis in endocrine autoimmunity: insights from Hashimoto's thyroiditis and Graves' disease
The approval of fremanezumab (AJOVY) by the HSE is very much welcomed by the many patients who suffer from migraine and is a significant addition to the treatment options available to Neurologists and Headache Specialists who treat migraine. Clodagh Kevans, Director, Specialty Medicines Ireland said: With over half a million people in Ireland suffering migraines, combined with the hugely disabling effects of migraines, this news represents a major step forward in offering migraine sufferers a much needed, and much anticipated, treatment option
Wang C, Yuan W, Hu A, Lin J, Xia Z, Yang CF, et al
For over two decades, GLP-1 has been heavily investigated as the most promising therapy target in type 2 diabetes patients
Customize skincare solutions based on your brand's unique visual appeal to enhance your beauty portfolio